Tvardi Therapeutics Ownership | Who Owns Tvardi Therapeutics?

Tvardi Therapeutics Ownership Summary

Tvardi Therapeutics is owned by 8.56% institutional investors, 34.64% insiders, and 56.80% retail investors. Slate path capital lp is the largest institutional shareholder, holding 9.49% of TVRD shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.75% of its assets in Tvardi Therapeutics shares.

TVRD Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Tvardi Therapeutics	8.56%	34.64%	56.80%
Sector	Healthcare Stocks	35.75%	11.89%	52.37%
Industry	Biotech Stocks	36.05%	11.82%	52.13%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Slate path capital lp	704.12K	9.49%	$2.24M
Blackrock funding, inc. /de	388.07K	5.23%	$1.23M
Vanguard group	424.82K	4.53%	$1.83M
American financial group	223.66K	3.01%	$711.24K
Geode capital management	182.34K	2.46%	$579.96K
683 capital management	176.03K	2.13%	$6.77M
Vestal point capital, lp	167.00K	2.03%	$6.51M
Silvercrest asset management group	101.03K	1.36%	$321.29K
State street	97.23K	1.31%	$309.19K
Renaissance	92.10K	1.24%	$292.88K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
683 capital management	176.03K	0.35%	$6.77M
Vestal point capital, lp	167.00K	0.29%	$6.51M
Parkman healthcare partners	65.00K	0.26%	$2.53M
American financial group	223.66K	0.26%	$711.24K
Duncan williams asset management	63.24K	0.06%	$201.11K
Slate path capital lp	704.12K	0.03%	$2.24M
Diadema partners lp	2.19K	0.02%	$85.15K
Persistent asset partners	500.00	0.01%	$19.48K
Boothbay fund management	20.19K	0.01%	$786.76K
Schonfeld strategic advisors	19.13K	0.00%	$745.57K

Top Buyers

Holder	Shares	% Assets	Change
Vestal point capital, lp	167.00K	0.29%	167.00K
Invesco	82.61K	0.00%	82.61K
Parkman healthcare partners	65.00K	0.26%	65.00K
Vanguard fiduciary trust	46.87K	-	46.87K
Aqr capital management	42.19K	0.00%	42.19K

Top Sellers

Holder	Shares	% Assets	Change
Jane street group	-	-	-47.44K
Marshall wace, llp	-	-	-24.98K
Farallon capital management	21.44K	0.00%	-21.79K
Quadrature capital	-	-	-20.96K
Squarepoint ops	32.68K	0.00%	-19.11K

New Positions

Holder	Shares	% Assets	Change	Value
Vestal point capital, lp	167.00K	0.29%	167.00K	$6.51M
Invesco	82.61K	0.00%	82.61K	$3.22M
Parkman healthcare partners	65.00K	0.26%	65.00K	$2.53M
Vanguard fiduciary trust	46.87K	-	46.87K	$149.05K
Aqr capital management	42.19K	0.00%	42.19K	$134.17K

Sold Out

Holder	Change
Cornerstone planning group	-1.00
Trust co of toledo na /oh/	-9.00
Kiker wealth management	-13.00
Raymond james financial	-65.00
Amalgamated bank	-169.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	32	-50.77%	634,949	-77.52%	8	0.94%	21	-52.27%	4	-33.33%
Dec 31, 2025	48	-28.36%	1,830,953	-29.68%	19	1.96%	33	-26.67%	4	-33.33%
Sep 30, 2025	37	-22.92%	1,220,244	-36.55%	14	3.50%	27	-43.75%	3	-
Jun 30, 2025	30	-	897,987	-	9	-	30	-	-	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	258.43K	2.75%	-
iShares Russell 2000 ETF	157.86K	1.68%	1.46K
Vanguard Institutional Extnd Mkt Idx Tr	86.28K	0.92%	-
Fidelity Small Cap Index	59.13K	0.63%	5.55K
Fidelity Extended Market Index	56.88K	0.61%	-208.00
iShares Russell 2000 Value ETF	35.46K	0.38%	-
Russell 2000 Equity Index Fund B	31.11K	0.33%	24.00
Vanguard Russell 2000 ETF	30.22K	0.32%	615.00
Extended Equity Market Fund E	20.82K	0.22%	3.00
Extended Equity Market Fund B	20.82K	0.22%	3.00

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	-
2026 Q1	-	-
2025 Q4	-	-
2025 Q3	-	-
2025 Q2	-	-

TVRD Ownership FAQ

Who Owns Tvardi Therapeutics?

Tvardi Therapeutics shareholders are primarily institutional investors at 8.56%, followed by 34.64% insiders and 56.80% retail investors. The average institutional ownership in Tvardi Therapeutics's industry, Biotech Stocks , is 36.05%, which Tvardi Therapeutics falls below.

Who owns the most shares of Tvardi Therapeutics?

Tvardi Therapeutics’s largest shareholders are Slate path capital lp (704.12K shares, 9.49%), Blackrock funding, inc. /de (388.08K shares, 5.23%), and Vanguard group (424.82K shares, 4.53%). Together, they hold 19.25% of Tvardi Therapeutics’s total shares outstanding.

Does Blackrock own Tvardi Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Tvardi Therapeutics.

Who is Tvardi Therapeutics’s biggest shareholder by percentage of total assets invested?

683 capital management is Tvardi Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.35% of its assets in 176.03K Tvardi Therapeutics shares, valued at 6.77M$.

Who is the top mutual fund holder of Tvardi Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Tvardi Therapeutics shares, with 2.75% of its total shares outstanding invested in 258.43K Tvardi Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools